General Information of the Cell Line
Cell Line ID
CL000200
Cell Line Name
SUP-T1
Synonyms
Sup-T1
SUPT-1
SupT-1
Sup T-1
SUP T-1
SUP T1
Sup T1
SupT1
SUPT1
Tsup-1
VB
Stanford University Pediatric T-cell line 1
Category
Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_1714
Tissue Information
Pleural effusion
Disease
Childhood T lymphoblastic lymphoma (NCIt: C7210)
T-cell non-Hodgkin lymphoma (ORDO: Orphanet_171918)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT02059, C-X-C chemokine receptor type 4
Compound ID Compound Name Compound Formula
CP0897003
4,7,10,17-tetraazabicyclo[11.3.1]heptadeca-1(16),13(17),14-trien-7-yl{4-[4,7,10,17-tetraazabicyclo[11.3.1]heptadeca-1(16),13(17),14-trien-7-ylmethyl]phenyl}methane;octahydrobromide
   Show/Hide
C34H51BrN8
 1
1
IC50 = 1 nM
   TI
   LI
   LO
   TS
CP0943584
1,4,8,11-tetraazacyclotetradecanyl[4-(1,4,8,11-tetraazacyclotetradecanylmethyl)phenyl]methane octahydrochloride;dihydrate
   Show/Hide
C28H66Cl8N8O2
 1
1
IC50 = 7 nM
   TI
   LI
   LO
   TS
CP0426218
(3R)-4-[[(2R)-6-amino-1-[[(2R)-6-amino-1-[[(2R)-1-[[6-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-[[(2S)-4-amino-1-[[(2S)-4-amino-1-[(2S)-2-[[(2S)-5-carbamimidamido-1-[[(2S,3R)-1-[[(1R)-1-carboxy-2-sulfanylethyl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-1,4-dioxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-6-oxohexyl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-[[(2R)-1-[(2R)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[2-[[(2R)-2-amino-4-methylpentanoyl]amino]acetyl]amino]propanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]-4-oxobutanoic acid
   Show/Hide
C122H206N46O33S
 2
1
IC50 = 14 nM
   TI
   LI
   LO
   TS
2
IC50 = 2870 nM
   TI
   LI
   LO
   TS
CP0402847
(3S)-3-[[2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[6-[[(2R)-2-[[(2R)-6-amino-2-[[(2R)-6-amino-2-[[(2R)-2-[[(2R)-1-[(2R)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[2-[[(2R)-2-amino-4-methylpentanoyl]amino]acetyl]amino]propanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]-3-carboxypropanoyl]amino]hexanoyl]amino]hexanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoylamino]hexanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]acetyl]amino]-4-[[(2S,3S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-amino-1-oxo-3-sulfanylpropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-4-oxobutanoic acid
   Show/Hide
C123H207N47O30S
 2
1
IC50 = 23 nM
   TI
   LI
   LO
   TS
2
IC50 = 4030 nM
   TI
   LI
   LO
   TS
CP0145769
1,1''-{1,4-phenylenebis(methylene)}-bis{1,4,8,11-tetraaza-cyclotetradecane}
   Show/Hide
C28H54N8
 4
1
IC50 = 39.777247 nM
   TI
   LI
   LO
   TS
2
IC50 = 44 nM
   TI
   LI
   LO
   TS
3
IC50 = 113.365155 nM
   TI
   LI
   LO
   TS
4
IC50 > 1988.862371 nM
   TI
   LI
   LO
   TS
CP0895050
1,5,8,11-tetraazacyclotetradecanyl[4-(1,5,8,11-tetraazacyclotetradecanylmethyl)phenyl]methane;octahydrobromide;dihydrate
   Show/Hide
C28H55BrN8
 1
1
IC50 = 67 nM
   TI
   LI
   LO
   TS
CP0866103
1',1'',1''',1'''',1''''',1'''''',1''''''',1'''''''',1''''''''',1'''''''''',1''''''''''',1''''''''''''-(5,5',5'',5''',5'''',5'''''-(1',1'',1''',1'''',1''''',1''''''-(5,5',5''-(1',1'',1'''-(benzene-1,3,5-triyltris(methylene))tris(4,4'-bipyridine-1,1'-diium-1',1-diyl))tris(methylene)tris(benzene-5,3,1-triyl))hexakis(methylene)hexakis(4,4'-bipyridine-1,1'-diium-1',1-diyl))hexakis(methylene)hexakis(benzene-5,3,1-triyl))dodecakis(methylene)dodecakis(1-ethyl-4,4'-bipyridine-1,1'-diium)hexafluorophosphate (V)
   Show/Hide
C324H318F252N42P42
 4
1
IC50 = 101.02114 nM
   TI
   LI
   LO
   TS
2
IC50 = 108.368132 nM
   TI
   LI
   LO
   TS
3
IC50 = 111.123254 nM
   TI
   LI
   LO
   TS
4
IC50 = 180.001304 nM
   TI
   LI
   LO
   TS
CP0037510
(S)-N-(2-Pyridinylmethyl)-N'-(1H-benzimidazol-2-ylmethyl)-N'-(5,6,7,8-tetrahydro-8-quinolinyl)-1,4-benzenedimethanamine
   Show/Hide
C31H32N6
 1
1
IC50 = 120 nM
   TI
   LI
   LO
   TS
CP0852033
1',1'',1''',1'''',1''''',1'''''',1''''''',1'''''''',1''''''''',1'''''''''',1''''''''''',1''''''''''''-(5,5',5'',5''',5'''',5'''''-(1',1'',1''',1'''',1''''',1''''''-(5,5',5''-(1',1'',1'''-(benzene-1,3,5-triyltris(methylene))tris(4',4''-bipyridine-1,1'-diium-1',1'-diyl))tris(methylene)tris(benzene-5,3,1-triyl))hexakis(methylene)hexakis(4'',4'''-bipyridine-1,1'-diium-1'',1'-diyl))hexakis(methylene)hexakis(benzene-5,3,1-triyl))dodecakis(methylene)dodecakis(1-(3-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propyl)-4'''''''',4'''''''''-bipyridine-1,1'-diium)hexafluorophosphate (V)
   Show/Hide
C396H390F252N66O24P42
 4
1
IC50 = 123.542202 nM
   TI
   LI
   LO
   TS
2
IC50 = 177.741362 nM
   TI
   LI
   LO
   TS
3
IC50 = 191.291152 nM
   TI
   LI
   LO
   TS
4
IC50 = 232.737568 nM
   TI
   LI
   LO
   TS
CP0559510
(3R)-4-[[(2R)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[2-[[(2R)-1-[[(2R)-5-amino-1-[[(2R)-6-amino-1-[[(2R)-1-[(2R)-2-[[(2R)-1-[(2R)-2-[[6-[[(2S)-6-amino-1-[[2-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1,6-diamino-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxohexan-2-yl]amino]-6-oxohexyl]carbamoyl]pyrrolidin-1-yl]-4-methyl-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-[[(2R)-1-[(2R)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[2-[[(2R)-2-amino-4-methylpentanoyl]amino]acetyl]amino]propanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]-4-oxobutanoic acid
   Show/Hide
C151H249N45O36S2
 1
1
IC50 = 147 nM
   TI
   LI
   LO
   TS
CP0562552
(3R)-4-[[(2R)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[2-[[(2R)-1-[[(2R)-5-amino-1-[[(2R)-6-amino-1-[[(2R)-1-[(2R)-2-[[(2R)-1-[(2R)-2-[[6-[[(2S)-6-amino-1-[[(2R)-6-amino-1-[[(2R)-1-[[(2R)-1-[[(2R)-1-[[(2R)-1-[[2-[[(2R)-1-[[(2R)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-6-oxohexyl]carbamoyl]pyrrolidin-1-yl]-4-methyl-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-[[(2R)-1-[(2R)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[2-[[(2R)-2-amino-4-methylpentanoyl]amino]acetyl]amino]propanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]-4-oxobutanoic acid
   Show/Hide
C168H265N49O38S2
 1
1
IC50 = 193 nM
   TI
   LI
   LO
   TS
CP0860686
1',1'',1''',1''''-(5,5'-(1',1''-(5-(1'-(3-((1'-(3,5-bis((1'-ethyl-4,4'-bipyridin-1,1'-diium-1-yl)methyl)benzyl)-4,4'-bipyridin-1,1'-diium-1-yl)methyl)-5-((1'-(3-((4-ethyl-1,4'-bipyridin-1,1'-diium-1'-yl)methyl)-5-((1'-ethyl-4,4'-bipyridin-1,1'-diium-1-yl)methyl)benzyl)-4,4'-bipyridin-1,1'-diium-1-yl)methyl)phenyl)-4,4'-bipyridin-1,1'-diium-1-yl)-1,3-phenylene)bis(methylene)bis(4,4'-bipyridine-1,1'-diium-1',1-diyl))bis(methylene)bis(benzene-5,3,1-triyl))tetrakis(methylene)tetrakis(1-ethyl-4,4'-bipyridine-1,1'-diium)hexafluorophosphate (V)
   Show/Hide
C198H194F156N26P26
 4
1
IC50 = 202.775641 nM
   TI
   LI
   LO
   TS
2
IC50 = 284.780495 nM
   TI
   LI
   LO
   TS
3
IC50 = 344.42039 nM
   TI
   LI
   LO
   TS
4
IC50 = 445.80821 nM
   TI
   LI
   LO
   TS
CP0852034
1',1'',1''',1'''',1''''',1'''''',1''''''',1''''''''-(5,5',5'',5'''-(1',1'',1''',1''''-(5,5'-(4,4'-bipyridine-1,1'-diium-1,1'-diyl)bis(benzene-5,3,1-triyl))tetrakis(methylene)tetrakis(4',4''-bipyridine-1,1'-diium-1',1'-diyl))tetrakis(methylene)tetrakis(benzene-5,3,1-triyl))octakis(methylene)octakis(1-(3-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propyl)-4',4''-bipyridine-1,1'-diium)hexafluorophosphate (V)
   Show/Hide
C246H242F156N42O16P26
 4
1
IC50 = 207.37513 nM
   TI
   LI
   LO
   TS
2
IC50 = 209.935317 nM
   TI
   LI
   LO
   TS
3
IC50 = 235.537185 nM
   TI
   LI
   LO
   TS
4
IC50 = 326.423816 nM
   TI
   LI
   LO
   TS
CP0866102
1',1'',1''',1'''',1''''',1''''''-(5,5',5''-(1',1'',1'''-(benzene-1,3,5-triyltris(methylene))tris(4,4'-bipyridine-1,1'-diium-1',1-diyl))tris(methylene)tris(benzene-5,3,1-triyl))hexakis(methylene)hexakis(1-(3-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propyl)-4,4'-bipyridine-1,1'-diium)hexafluorophosphate (V)
   Show/Hide
C174H174F108N30O12P18
 4
1
IC50 = 231.463762 nM
   TI
   LI
   LO
   TS
2
IC50 = 351.752017 nM
   TI
   LI
   LO
   TS
3
IC50 = 402.783397 nM
   TI
   LI
   LO
   TS
4
IC50 = 515.781454 nM
   TI
   LI
   LO
   TS
CP0504536
N-(1H-benzimidazol-2-ylmethyl)-N-[[4-[(pyridin-2-ylmethylamino)methyl]phenyl]methyl]-5,6,7,8-tetrahydroquinolin-8-amine
   Show/Hide
C31H32N6
 1
1
IC50 = 250 nM
   TI
   LI
   LO
   TS
CP0860688
1',1'',1''',1'''',1''''',1''''''-(5,5',5''-(1',1'',1'''-(benzene-1,3,5-triyltris(methylene))tris(4,4'-bipyridine-1,1'-diium-1',1-diyl))tris(methylene)tris(benzene-5,3,1-triyl))hexakis(methylene)hexakis(1-ethyl-4,4'-bipyridine-1,1'-diium)hexafluorophosphate (V)
   Show/Hide
C138H138F108N18P18
 4
1
IC50 = 259.764795 nM
   TI
   LI
   LO
   TS
2
IC50 = 309.141574 nM
   TI
   LI
   LO
   TS
3
IC50 = 377.839702 nM
   TI
   LI
   LO
   TS
4
IC50 = 463.712361 nM
   TI
   LI
   LO
   TS
CP0853531
1',1'',1''',1''''-(5,5'-(4,4'-bipyridine-1,1'-diium-1,1'-diyl)bis(benzene-5,3,1-triyl))tetrakis(methylene)tetrakis(1-ethyl-4,4'-bipyridine-1,1'-diium)hexafluorophosphate
   Show/Hide
C74H74F60N10P10
 4
1
IC50 = 544.436176 nM
   TI
   LI
   LO
   TS
2
IC50 = 767.694176 nM
   TI
   LI
   LO
   TS
3
IC50 = 3364.537229 nM
   TI
   LI
   LO
   TS
4
IC50 = 5800.791195 nM
   TI
   LI
   LO
   TS
CP0383950
(3R)-3-[[(2R)-1-[(2R)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[2-[[(2R)-2-amino-4-methylpentanoyl]amino]acetyl]amino]propanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-4-[[(2R)-1,6-diamino-1-oxohexan-2-yl]amino]-4-oxobutanoic acid
   Show/Hide
C52H80N18O13
 1
1
IC50 = 615 nM
   TI
   LI
   LO
   TS
CP0857948
1',1'',1''',1''''-(5,5'-(4,4'-bipyridine-1,1'-diium-1,1'-diyl)bis(benzene-5,3,1-triyl))tetrakis(methylene)tetrakis(1-(3-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propyl)-4,4'-bipyridine-1,1'-diium)hexafluorophosphate (V)
   Show/Hide
C98H98F60N18O8P10
 4
1
IC50 = 660.097888 nM
   TI
   LI
   LO
   TS
2
IC50 = 724.497682 nM
   TI
   LI
   LO
   TS
3
IC50 = 3078.310149 nM
   TI
   LI
   LO
   TS
4
IC50 = 3403.529109 nM
   TI
   LI
   LO
   TS
CP0957174
3,6,9,15-tetraazabicyclo[9.3.1]pentadeca-1(14),11(15),12-trien-6-yl{4-[3,6,9,15-tetraazabicyclo[9.3.1]pentadeca-1(14),11(15),12-trien-6-ylmethyl]phenyl}methane;octahydrobromide
   Show/Hide
C30H43BrN8
 1
1
IC50 = 4363 nM
   TI
   LI
   LO
   TS
CP0881765
15-chloro-3,7,11,17-tetraazabicyclo[11.3.1]heptadeca-1(16),13(17),14-trien-7-yl{4-[15-chloro-3,7,11,17-tetraazabicyclo[11.3.1]heptadeca-1(16),13(17),14-trien-7-ylmethyl]phenyl}methane;hexahydrobromide;acetic acid
   Show/Hide
C36H53BrCl2N8O2
 1
1
IC50 = 5737 nM
   TI
   LI
   LO
   TS
CP0402848
(2R)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-1-[(2S)-4-amino-2-[[(2S)-4-amino-2-[[(2S)-4-amino-2-[[(2S,3R)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-6-amino-2-(6-aminohexanoylamino)hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]-3-hydroxybutanoyl]amino]-4-oxobutanoyl]amino]-4-oxobutanoyl]amino]-4-oxobutanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-hydroxybutanoyl]amino]-3-sulfanylpropanoic acid
   Show/Hide
C58H105N23O18S
 1
1
IC50 = 7418 nM
   TI
   LI
   LO
   TS
CP0418003
(R)-N-(2-Pyridinylmethyl)-N'-(1H-benzimidazol-2-ylmethyl)-N'-(5,6,7,8-tetrahydro-8-quinolinyl)-1,4-benzenedimethanamine
   Show/Hide
C31H32N6
 1
1
IC50 = 29200 nM
   TI
   LI
   LO
   TS
CP0861180
7-{4-[15-hydroxy-3,7,11,17-tetraazabicyclo[11.3.1]heptadeca-1(16),13(17),14-trien-7-ylmethyl]benzyl}-3,7,11,17-tetraazabicyclo[11.3.1]heptadeca-1(16),13(17),14-trien-15-ol;octahydrobromide
   Show/Hide
C34H51BrN8O2
 1
1
IC50 > 35000 nM
   TI
   LI
   LO
   TS
CP0879082
5,8-dioxa-1,12-diazacyclotetradecanyl[4-(5,8-dioxa-1,12-diazacyclotetradecanylmethyl)phenyl]methane;tetra hydrochloride;2.5 hydrate
   Show/Hide
C28H51ClN4O4
 1
1
IC50 > 35000 nM
   TI
   LI
   LO
   TS
CP0879270
5,8-dithia-1,12-diazacyclotetradecanyl[4-(5,8-dithia-1,12-diazacyclotetradecanylmethyl)phenyl]methane;tetra hydrochloride
   Show/Hide
C28H51ClN4S4
 1
1
IC50 > 35000 nM
   TI
   LI
   LO
   TS
CP0890584
3,7,11,15,17-pentaazabicyclo[11.3.1]heptadeca-1(16),13(17),14-trien-7-yl{4-[3,7,11,15,17-pentaazabicyclo[11.3.1]heptadeca-1(16),13(17),14-trien-7-ylmethyl]phenyl}methane;heptahydrobromide;dacetic acid
   Show/Hide
C34H53BrN10O2
 1
1
IC50 > 35000 nM
   TI
   LI
   LO
   TS
CP0951801
1,5,11-triazacyclotetradecanyl[4-(1,5,11-triazacyclotetradecanylmethyl)phenyl]methane ;hexahydrobromide;5hydrate
   Show/Hide
C30H57BrN6
 1
1
IC50 > 35000 nM
   TI
   LI
   LO
   TS
CP0384173
(3S)-3-[[2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-6-amino-2-(6-aminohexanoylamino)hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]acetyl]amino]-4-[[(2S,3S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-amino-1-oxo-3-sulfanylpropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-4-oxobutanoic acid
   Show/Hide
C59H106N24O15S
 1
1
IC50 > 50000 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Pleural effusion)
Cell Line Name Organism Disease
U-937 Homo sapiens (Human) Adult acute monocytic leukemia
SU-DHL-1 Homo sapiens (Human) Anaplastic large cell lymphoma, ALK-positive
SR Homo sapiens (Human) Anaplastic large cell lymphoma, ALK-positive
MC116 Homo sapiens (Human) B-cell non-Hodgkin lymphoma
K-562 Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
K562/A02 Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
K562/Adr Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
K562/R7 Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
K562/DOX Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
MDA-MB-231 Homo sapiens (Human) Breast adenocarcinoma
MDA-MB-415 Homo sapiens (Human) Breast adenocarcinoma
MDA-MB-468 Homo sapiens (Human) Breast adenocarcinoma
SK-BR-3 Homo sapiens (Human) Breast adenocarcinoma
AU565 Homo sapiens (Human) Breast adenocarcinoma
CAL-51 Homo sapiens (Human) Breast carcinoma
CAL-120 Homo sapiens (Human) Breast carcinoma
DG-75 Homo sapiens (Human) Burkitt lymphoma
Pfeiffer Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
WSU-DLCL2 Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
Karpas-422 Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
DoHH2 Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
KATO III Homo sapiens (Human) Down syndrome
GIST-T1 Homo sapiens (Human) Gastrointestinal stromal tumor
GIST-5R Homo sapiens (Human) Gastrointestinal stromal tumor
MZ-CRC-1 Homo sapiens (Human) Hereditary thyroid gland medullary carcinoma
L-428 Homo sapiens (Human) Hodgkin lymphoma
KM-H2 Homo sapiens (Human) Hodgkin lymphoma
T-47D Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/2a Homo sapiens (Human) Invasive breast carcinoma of no special type
T-47 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7 MX100 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/VP Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7-2a Homo sapiens (Human) Invasive breast carcinoma of no special type
T47D:A18 Homo sapiens (Human) Invasive breast carcinoma of no special type
MVLN Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF/MX Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/Topo Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/NOD2 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7aro Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/MRP1-M6 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/MRP1-10 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/MRP1-M24 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/NOD1 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7piGST Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7-Y1 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/ADM Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7:WS8 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7-FLV1000 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7-neo/Her2 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7 cl.24 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/DX1 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7-LC3 Homo sapiens (Human) Invasive breast carcinoma of no special type
T47D-KBluc Homo sapiens (Human) Invasive breast carcinoma of no special type
Calu-6 Homo sapiens (Human) Lung adenocarcinoma
Calu-3 Homo sapiens (Human) Lung adenocarcinoma
HCC78 Homo sapiens (Human) Lung adenocarcinoma
NCI-H3122 Homo sapiens (Human) Lung adenocarcinoma
NCI-H3255 Homo sapiens (Human) Lung adenocarcinoma
NCI-H2122 Homo sapiens (Human) Lung adenocarcinoma
COR-L105 Homo sapiens (Human) Lung adenocarcinoma
NCI-H1437 Homo sapiens (Human) Lung adenocarcinoma
HCC4006 Homo sapiens (Human) Lung adenocarcinoma
NCI-H1792 Homo sapiens (Human) Lung adenocarcinoma
DFCI032 Homo sapiens (Human) Lung adenocarcinoma
NCI-H1355 Homo sapiens (Human) Lung adenocarcinoma
NCI-H460 Homo sapiens (Human) Lung large cell carcinoma
U-1810 Homo sapiens (Human) Lung large cell carcinoma
COR-L23/R Homo sapiens (Human) Lung large cell carcinoma
H460/MX20 Homo sapiens (Human) Lung large cell carcinoma
H460R Homo sapiens (Human) Lung large cell carcinoma
H69AR Homo sapiens (Human) Lung small cell carcinoma
NCI-H69 Homo sapiens (Human) Lung small cell carcinoma
GLC-4/ADR Homo sapiens (Human) Lung small cell carcinoma
STC 1 Homo sapiens (Human) Lung small cell carcinoma
RERF-LC-A1 Homo sapiens (Human) Lung squamous cell carcinoma
Calu-1 Homo sapiens (Human) Lung squamous cell carcinoma
HCC95 Homo sapiens (Human) Lung squamous cell carcinoma
RERF-LC-AI Tet-off Homo sapiens (Human) Lung squamous cell carcinoma
NCI-H1650 Homo sapiens (Human) Minimally invasive lung adenocarcinoma
NCI-H1666 Homo sapiens (Human) Minimally invasive lung adenocarcinoma
NCI-H929 Homo sapiens (Human) Plasma cell myeloma
KMS-11 Homo sapiens (Human) Plasma cell myeloma
UTMC-2 Homo sapiens (Human) Plasma cell myeloma
KMS-12-PE Homo sapiens (Human) Plasma cell myeloma
NCI-H226 Homo sapiens (Human) Pleural epithelioid mesothelioma
Karpas-1106P Homo sapiens (Human) Primary mediastinal (thymic) large B-cell lymphoma